Garrett Q2 Beat and Raised Outlook Eases Margin Worries, Shifts Thesis to Hold

What happened

Garrett Motion's second-quarter 2026 results surpassed expectations, with broad-based sales growth and margin gains driving the beat and leading management to lift its full-year guidance. This performance directly counters the prior thesis that margin compression from pricing headwinds and shifting mix would erode profitability, as productivity and volume offset those pressures. The raised outlook suggests the company is on track to sustain EBIT margins at or above 14%, a key threshold that would have shifted the rating to WAIT under the previous assessment. While the stock's valuation remains full and leverage high, the improved earnings trajectory reduces the immediate downside risk that had justified a POTENTIAL SELL call. Investors should now reassess the risk-reward, acknowledging that the margin narrative is stronger, but long-term structural challenges in the ICE-to-EV transition have not disappeared.

Implication

Garrett's ability to deliver above-consensus Q2 results and improve its 2026 outlook suggests that operational momentum is stronger than previously modeled, reducing the likelihood of a sharp margin correction. This shifts the investment case from caution to a hold, with an upgraded base-case value potentially near $20. However, the company's leveraged balance sheet, dependence on capital returns, and eventual turbo volume declines remain risks; a failure to commercialize zero-emission products by 2027 would still pressure long-term earnings. Investors who trimmed earlier may now miss a favorable re-entry below $15, while current holders can allow the stock room to run toward the $22 bull case if execution continues. Any sign of guidance not being met or capital allocation missteps should be closely monitored.

Thesis delta

The original 'POTENTIAL SELL' rating was based on margin normalization risk and a stretched valuation; Q2 2026's beat and raised outlook directly counter those concerns, indicating that margins are holding up better than anticipated. As a result, the thesis shifts from sell to neutral, with a base-case value estimate now approaching $20, reducing immediate downside. The stock may be more appropriately rated WAIT or HOLD until further clarity on 2027+ zero-emission commercialization.